Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”

---

In the article titled “HDR Brachytherapy in the Management of High-Risk Prostate Cancer” [1], there was an error in Table 2, which should be corrected as follows: For Hoskin et al. [32], the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.

Table 2 

Estimated equivalent doses (2 Gy per fraction) for published HDR schedules using the EQD2 formula, assuming for prostate cancer of 1.5 Gy [19].